Novavax Inc (NVAX)

Operating Expenses

$97.36M

Quarterly · Period ending: · USD

NVAX logo

NVAX Operating Expenses

Latest reported$97.36M
NVAX Quarterly Operating Expenses ($1.30M → $97.36M)
High-resolution chart · PNG

NVAX operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novavax Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
97,358,000
124,249,000
100,915,000
226,967,000
119,345,000
137,027,000
182,722,000
157,911,000
208,244,000
183,777,000
326,034,000
48,767,000
313,192,000
272,254,000
349,940,000
427,173,000
397,808,000
380,174,000
98,462,000
485,988,000
643,846,000
655,861,000
462,512,000
350,966,000
52,565,000
26,274,000
37,521,000
26,510,000
40,023,000
44,205,000
52,639,000
49,635,000
52,766,000
53,166,000
58,197,000
49,980,000
48,203,000
46,506,000
59,444,000
66,539,000
79,003,000
79,480,000
84,755,000
36,977,000
32,130,000
31,731,000
35,551,000
23,976,000
21,008,000
18,826,000
20,398,000
17,805,000
14,797,000
12,126,000
12,109,000
8,776,000
7,840,000
8,323,000
3,101,000
8,976,000
8,922,000
8,264,000
7,083,000
10,714,000
9,475,000
11,564,000
14,228,000
8,463,000
7,859,000
7,158,000
9,280,000
9,920,000
8,546,000
7,678,000
5,715,000
9,476,000
8,028,000
8,256,000
5,279,000
5,717,000
6,716,000
4,790,000
-5,181,000
3,036,000
5,513,000
7,400,000
10,592,000
2,609,000
8,844,000
7,853,000
6,435,000
6,468,000
6,519,000
6,361,000
5,860,000
8,044,000
8,971,000
10,131,000
8,039,000
6,588,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.